TCL Archive Advisors Approve Lung Screening Trial Testing Spiral CT Vs. X-Ray, For $200M. November 23, 2001
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004